RABIES VACCINE MARKET ANALYSIS
Global Rabies Vaccines Market- Drivers
Key players are focused on research and development strategies which are expected to drive the global rabies vaccine market growth during the forecast period. For instance, in 2017, CPL Laboratories (India), a joint venture biotechnology company established in 2009 by Novavax Inc., USA and Cadila Pharmaceuticals Limited, stated that Nano- particle vaccine of baculvirous-derived glycoprotein, a four dose regime vaccine is in phase-3 human trial, and is expected to be approved by 2021.
Global Rabies Vaccine Market- Competitive Landscape
Key players operating in global rabies vaccine market are Sanofi S.A., Novartis International AG, Serum Institute of India Pvt. Ltd, Indian Immunologicals Limited, Bharat Biotech Ltd, Zuventus HealthCare Ltd., Cpl Biologicals Private Limited, Yisheng Biopharma Co., Ltd, GlaxoSmithKline plc, Bavarian Nordic A/S, and Chiron Behring Vaccines Private Limited.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
